Print
A new peer-reviewed study published in Ophthalmic Epidemiology has revealed alarming findings about the impact of Pfizer’s COVID-19 mRNA injection (BNT162b2) on the eye’s corneal endothelium.
The study, titled “Evaluation of the Effects of mRNA-COVID 19 Vaccines on Corneal Endothelium,” provides evidence of significant structural damage to this critical layer of cells, which are responsible for maintaining corneal transparency and hydration.
The Study and Its Findings
Conducted by researchers from two Turkish university hospitals, the study involved 64 healthy, COVID-naive volunteers. Using advanced imaging tools such as Sirius corneal topography and Tomey EM-4000 specular microscopy, the researchers evaluated 128 eyes before vaccination and approximately 75 days after the second Pfizer dose. The key findings are as follows:
- Endothelial Cell Density (ECD): Decreased from 2597 cells/mm² to 2378 cells/mm², resulting in an 8.4% loss in just 75 days (p < 0.001).
- Cell Variation (CV): Increased from 39% to 42%, indicating rising cell stress and loss of uniformity (p < 0.001).
- Hexagonality (% of healthy cells): Dropped from 50% to 48% (p < 0.001), signifying a loss of normal shape and signs of dysfunction.
- Central Corneal Thickness (CCT): Increased from 533 μm to 548 μm (p < 0.001), suggesting fluid imbalance and corneal edema
Implications of the Findings
The corneal endothelium is a non-renewable layer of cells that does not regenerate. Once these cells are lost, they cannot be replaced, and the damage is considered irreversible. Sustained injury to this layer may result in blurred vision, chronic corneal swelling, or even blindness in severe cases.
This study provides objective, measurable evidence of structural and functional eye damage shortly after mRNA COVID-19 injection, even in young, healthy adults with no prior ocular pathology.
Broader Context and Concerns
The findings of this study add to the growing body of evidence regarding the potential side effects of mRNA vaccines.
While the benefits of COVID-19 vaccination are widely recognized, these results highlight the need for continued surveillance and monitoring of vaccine recipients, particularly those with pre-existing ocular vulnerabilities or a history of corneal transplantation. The study emphasizes that “the endothelium should be closely monitored in those with a low endothelial count or who have had a corneal graft.”
Furthermore, the study’s results align with other research indicating that mRNA vaccines can cause a range of rare side effects, including myocarditis and pericarditis, particularly in younger men.
These findings underscore the importance of balancing the benefits of vaccination against the potential risks and the need for personalized medical advice, especially for individuals with underlying health conditions.
Conclusion
The study published in Ophthalmic Epidemiology offers a stark reminder of the potential impacts of mRNA COVID-19 vaccines on eye health. While the long-term consequences of these changes are not yet fully understood, the irreversible nature of the damage to the corneal endothelium warrants close attention and further research.
As we continue to navigate the COVID-19 pandemic, it is crucial to consider all potential side effects and ensure that individuals are fully informed about the risks of dangerous vaccinations.
